Prevalence of Primary Chronic Headache in a Population-Based Sample of 30- to 44-Year-Old Persons
The Akershus Study of Chronic HeadacheGrande R.B.a-c · Aaseth K.a, b, d · Gulbrandsen P.a, d, e · Lundqvist C.a, e, f · Russell M.B.a, b, d, g
aHead and Neck Research Group, Akershus University Hospital, Nordbyhagen, bDepartment of Neurology, Akershus University Hospital, Lørenskog, cFaculty Division Ullevaal University Hospital, University of Oslo, Oslo, dFaculty Division Akershus University Hospital, University of Oslo, Nordbyhagen, eHelse Øst Health Services Research Centre, Akershus University Hospital, Lørenskog, fDepartment of Neurology, Ullevaal University Hospital, Oslo, gCenter of Research, Akershus University Hospital, Lørenskog, Norway
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Prevalence data on primary chronic headache in the general population based on clinical interviews by physicians are lacking. Methods: In a cross-sectional epidemiological survey, a random sample of 30,000 persons from Akershus County, aged 30–44 years, were sent a postal questionnaire. Those with self-reported chronic headache within the last month and/or year were invited to a semi-structured diagnostic interview and a physical and neurological examination conducted by 2 neurological residents with experience in headache diagnostics. The diagnoses were made according to the International Classification of Headache Disorders, 2nd edition, 2004, and relevant revisions. Results: The questionnaire response rate was 71%, and the participation rate of the interview was 74%. The 1-year prevalence of primary chronic headache was 2.9%. Chronic tension-type headache (CTTH) and probable chronic tension-type headache (pCTTH) had 1-year prevalences of 1.6 and 1.2%, respectively. The prevalences of other primary chronic headaches were: chronic migraine (CM) 0.01%, probable CM 0.09% and other subtypes 0.04%. Co-occurrence of migraine was frequent, as 42% with CTTH and 55% with pCTTH had migraine. Conclusion: Primary chronic headache is prevalent in the general population. The majority has CTTH or pCTTH, while CM and other primary chronic headaches are rare.
© 2008 S. Karger AG, Basel
WHO: http://www who int/mental_health/neurology/headache/en/print html.
- Rasmussen BK, Jensen R, Olesen J: Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992;46:443–446.
- Zeeberg P, Olesen J, Jensen R: Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26:1192–1198.
- Colas R, Munoz P, Temprano R, Gomez C, Pascual J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338–1342.
- Castillo J, Munoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999;39:190–196.
Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24 (suppl):1–160.
- Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ, International Headache Society: The International Classification of Headache Disorders, 2nd edition (ICHD-II) – revision of criteria for 8.2 medication overuse headache. Cephalalgia 2005;25:460–465.
- Erratum. Cephalalgia 2006;26:360.
- Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742–746.
- Hagen K, Zwart J-A, Vatten L, Stovner LJ, Bovim G: Prevalence of migraine and non-migrainous headache – Head HUNT, a large population-based study. Cephalalgia 2000;20:900–906.
- Gobel H, Petersen-Braun M, Soyka D: The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994;14:97–106.
- Russell MB: Tension-type headache in 40-year-olds: a Danish population-based sample of 4,000. J Headache Pain 2005;6:441–447.
- Wiendels NJ, Knuistingh NA, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ, Ferrari MD: Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006;26:1434–1442.
- Wang SJ, Fuh JL, Lu SR, Juang KD: Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006;66:193–197.
- Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population – a prevalence study. J Clin Epidemiol 1991;44:1147–1157.
- Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000;54:314–319.
- Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001;21:980–986.
- Zwart JA, Dyb G, Holmen TL, Stovner LJ, Sand T: The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trondelag Health Study (Head-HUNT-Youth), a large population-based epidemiological study. Cephalalgia 2004;24:373–379.
Lowry R: VassarStats: web site for statistical computation. http://faculty vassar edu/lowry/VassarStats html.
- Rasmussen BK, Jensen R, Olesen J: Questionnaire versus clinical interview in the diagnosis of headache. Headache 1991;31:290–295.
- Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J: Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 1995;24:612–618.
- Russell MB, Levi N, Saltyte-Benth J, Fenger K: Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol 2006;21:153–160.
- Stovner LJ: Headache epidemiology: how and why? J Headache Pain 2006;7:141–144.
- Lavados PM, Tenhamm E: Epidemiology of tension-type headache in Santiago, Chile: a prevalence study. Cephalalgia 1998;18:552–558.
- Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998;38:497–506.
- Lanteri-Minet M, Auray JP, El HA, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF: Prevalence and description of chronic daily headache in the general population in France. Pain 2003;102:143–149.
- Hagen K, Zwart J-A, Vatten L, Stovner LJ, Bovim G: Head-HUNT: validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia 2000;20:244–251.
- Russell MB, Aaseth K, Grande RB, Gulbrandsen P, Lundqvist C: Which strategy should be applied? Design of a Norwegian epidemiological survey on chronic headache. Acta Neurol Scand Suppl 2007;187:59–63.
- Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994;34:1–7.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.